Dr Animesh Singh is a Consultant in Rheumatology and General Medicine working privately at The Physicians' Clinic, The Princess Grace Hospital and Chiswick Medical Centre. His NHS base is the Royal Free Hospital in Hampstead.
He aims to offer holistic, evidence-based care to all his patients. He takes pride in treating individual patients and not just their medical problems and runs his clinics in a collaborative fashion with his patients, maintaining great respect for their beliefs and background.
He is proficient in the management of patients with all types of rheumatological disorders with particular interest in rheumatoid and psoriatic arthritis, polymyalgia rheumatica (PMR), osteoporosis, gout and lupus (SLE). In addition, he is heavily involved with acute and general medicine including the assessment and management of acutely sick patients as well as the investigation of complex undifferentiated symptoms. He participates in the medical on call rota at both the Royal Free and Princess Grace Hospitals.
At the Royal Free, he is clinical governance lead in acute medicine and psoriatic arthritis lead, running a unique collaborative clinic with dermatology consultants. He is an educational supervisor for junior doctors, clinical tutor for undergraduate medical students and principal investigator in a number of clinical trials.
Dr Animesh Singh undertook his undergraduate training medical training at University College London, qualifying in 2005. During this period, he undertook an additional BSc in Immunology where he was awarded first-class honours. He researched the pathogenesis of rheumatoid arthritis and its modulation by anti-TNF therapy at the prestigious Windeyer Institute, UCL under Prof. Isenberg and Prof. Ehrenstein resulting in a number of awards including from Arthritis Research UK.
Dr Singh’s postgraduate general medical and rheumatology training was across north and west London at a mixture of extremely busy district-general and world-renowned teaching hospitals. He undertook a further period of research working for a multinational pharmaceutical company setting up and running pivotal clinical trials in scleroderma (systemic sclerosis) and cytokine-release syndrome in leukaemia patients.
He is a member of the British Society of Rheumatology and European League Against Rheumatism.